Next Article in Journal
IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia
Next Article in Special Issue
Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
Previous Article in Journal
Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines 2022, 10, 130
Previous Article in Special Issue
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment
 
 
Article

Article Versions Notes

Biomedicines 2024, 12(1), 87; https://doi.org/10.3390/biomedicines12010087
Action Date Notes Link
article xml file uploaded 30 December 2023 08:07 CET Original file -
article xml uploaded. 30 December 2023 08:07 CET Update -
article pdf uploaded. 30 December 2023 08:07 CET Version of Record https://www.mdpi.com/2227-9059/12/1/87/pdf-vor
article supplementary file uploaded. 30 December 2023 08:07 CET - https://www.mdpi.com/2227-9059/12/1/87#supplementary
article html file updated 30 December 2023 08:09 CET Original file -
article xml file uploaded 4 January 2024 07:18 CET Update -
article xml uploaded. 4 January 2024 07:18 CET Update https://www.mdpi.com/2227-9059/12/1/87/xml
article pdf uploaded. 4 January 2024 07:18 CET Updated version of record https://www.mdpi.com/2227-9059/12/1/87/pdf
article html file updated 4 January 2024 07:20 CET Update -
article supplementary file uploaded. 5 January 2024 10:43 CET - https://www.mdpi.com/2227-9059/12/1/87#supplementary
article html file updated 5 January 2024 10:45 CET Update https://www.mdpi.com/2227-9059/12/1/87/html
Back to TopTop